A Study of Palbociclib in Combination With Bazedoxifene in Hormone Receptor Positive Breast Cancer

NCT02448771 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

COMPLETED

Status

36

Enrollment

OTHER

Sponsor class

Conditions

Breast Cancer Stage IV
Unresectable Locally Advanced Invasive Breast Cancer
Metastatic Invasive Breast Cancer

Interventions

DRUG: Palbociclib
DRUG: Bazedoxifene

Sponsor

Dana-Farber Cancer Institute

Collaborators

[object Object]